NASDAQ: IVA - Inventiva S.A.

六个月盈利: -22.8%
部门: Healthcare

促销时间表 Inventiva S.A.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0275
EV/EBITDA 1.23
IPO date 2020-07-10
ISIN US46124U1079
Industry Biotechnology
P/BV 3.6
P/S 1074.79
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.007
Сайт https://www.inventivapharma.com
Цена ао 3.78
Число акций ао 0.04535 млрд
每日价格变化: -1.78% (2.2399)
每周价格变化: -6.38% (2.35)
每月价格变化: -17.91% (2.68)
3个月内价格变化: +19.57% (1.84)
六个月内的价格变化: -22.8% (2.85)
每年价格变化: -51.28% (4.516)
3年内价格变化: -84.5% (14.19)
5年内价格变化: 0% (2.2001)
10年价格变化: 0% (2.2001)
年初以来价格变化: -3.5% (2.28)
所有参数

低估

姓名 意义 年级
P/S 10.36 1
P/BV -6.17 0
P/E 0 0
EV/EBITDA -1.81 0
全部的: 3.75

效率

姓名 意义 年级
ROA, % -176.54 0
ROE, % 376.22 10
全部的: 3.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.2841 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 140.79 10
盈利能力 Ebitda, % 260.61 10
盈利能力 EPS, % 77.78 8
全部的: 9.6
更多详情

机构 体积 分享, %
Yiheng Capital Management, L.P. 2644926 5.08
NEA Management Company, LLC 1462586 2.81
BVF Inc. 686040 1.32
Commonwealth Equity Services, LLC 36265 0.07
TWO SIGMA SECURITIES, LLC 13005 0.02
Ewa, LLC 11898 0.02
Morgan Stanley 5900 0.01
UBS Group AG 254 0



导师 职称 支付 出生年份
Mr. Frederic Cren Co-Founder, CEO & Chairman 521.29k 1966 (59 年)
Dr. Pierre Broqua Ph.D. Co-Founder, Chief Scientific Officer, Deputy CEO & Director 450.22k 1962 (63 年)
Mr. Jean Volatier Deputy GM & CFO N/A 1964 (61 年)
Mr. Eric Duranson L.L.M. General Counsel N/A 1974 (51 年)
Ms. Nathalie Harroy Head of Human Resources N/A 1967 (58 年)
Dr. Michael Cooreman Chief Medical Officer N/A 1958 (67 年)
Ms. Alice Roudot-Ketelers Pharm.D. Chief Operating Officer N/A 1971 (54 年)
Ms. Pascaline Clerc Ph.D. Executive Vice President of Strategy & Corporate Affairs N/A 1980 (45 年)
Dr. Kristina Meyer Ph.D. Executive VP and Business Development & Alliance Management

地址: France, Daix, 50 rue de Dijon - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.inventivapharma.com